Cargando…
Can Prescribed Cannabinoids Substitute Cannabis?
Legislative changes in the last years have made possible the prescription of medical cannabis in several countries, often following a growing public demand. However, the medical indications for use and the access to prescribed cannabis are still limited. Prescribers face several challenges in the fo...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566991/ http://dx.doi.org/10.1192/j.eurpsy.2022.145 |
_version_ | 1784809289288777728 |
---|---|
author | Batalla, A. |
author_facet | Batalla, A. |
author_sort | Batalla, A. |
collection | PubMed |
description | Legislative changes in the last years have made possible the prescription of medical cannabis in several countries, often following a growing public demand. However, the medical indications for use and the access to prescribed cannabis are still limited. Prescribers face several challenges in the form of barriers and dilemmas, often related to stigma, and deficient information and training. As a result, many people keep on using illicit cannabis for medical problems. In this session we will outline the most common controversies of cannabis prescription, particularly in psychiatry. We will discuss the ethical considerations regarding prescription practices, the benefit-risk assessment, the limitations of the current knowledge, and some potential solutions to respond to the strong demand from patients and families. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9566991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95669912022-10-17 Can Prescribed Cannabinoids Substitute Cannabis? Batalla, A. Eur Psychiatry Pharmacology Legislative changes in the last years have made possible the prescription of medical cannabis in several countries, often following a growing public demand. However, the medical indications for use and the access to prescribed cannabis are still limited. Prescribers face several challenges in the form of barriers and dilemmas, often related to stigma, and deficient information and training. As a result, many people keep on using illicit cannabis for medical problems. In this session we will outline the most common controversies of cannabis prescription, particularly in psychiatry. We will discuss the ethical considerations regarding prescription practices, the benefit-risk assessment, the limitations of the current knowledge, and some potential solutions to respond to the strong demand from patients and families. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9566991/ http://dx.doi.org/10.1192/j.eurpsy.2022.145 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Pharmacology Batalla, A. Can Prescribed Cannabinoids Substitute Cannabis? |
title | Can Prescribed Cannabinoids Substitute Cannabis? |
title_full | Can Prescribed Cannabinoids Substitute Cannabis? |
title_fullStr | Can Prescribed Cannabinoids Substitute Cannabis? |
title_full_unstemmed | Can Prescribed Cannabinoids Substitute Cannabis? |
title_short | Can Prescribed Cannabinoids Substitute Cannabis? |
title_sort | can prescribed cannabinoids substitute cannabis? |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566991/ http://dx.doi.org/10.1192/j.eurpsy.2022.145 |
work_keys_str_mv | AT batallaa canprescribedcannabinoidssubstitutecannabis |